Ad26.cov2-s/prednisoneFocal segmental glomerulosclerosis and no therapeutic response: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1936卷 / 1期

关键词：

D O I：

10.1007/s40278-022-29216-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：19 / 19

相关论文

共 50 条

[1] Ad26.cov2-s/tozinameranMinimal change disease and podocytopathic focal segmental glomerulosclerosis: 3 case reports
Reactions Weekly, 2022, 1905 (1) : 17 - 17
[2] Ad26.cov2-s/elasomeranDRESS syndrome: case report
Reactions Weekly, 2022, 1927 (1) : 20 - 20
[3] Ad26.CoV2-S/heparinVarious toxicities: case report
Reactions Weekly, 2021, 1882 (1) : 23 - 23
[4] Ad26.cov2-s/elasomeranRecurrent generalised anhidrosis: case report
Reactions Weekly, 2023, 1957 (1) : 17 - 17
[5] Ad26.cov2-s/immune-globulinImmune mediated thrombocytopenia and no response: case report
Reactions Weekly, 2021, 1873 (1) : 18 - 18
[6] Ad26.cov2-s/elasomeran/tozinameranSensorineural Hearing Loss: case report
Reactions Weekly, 2022, 1906 (1) : 20 - 20
[7] Ad26.cov2-s/albumin-humanLack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 16 - 16
[8] Ad26.cov2-s/elasomeranDemyelinating neuropathy: 2 case reports
Reactions Weekly, 2022, 1917 (1) : 22 - 22
[9] Ad26.cov2-s/tozinameranMyocarditis: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 22 - 22
[10] Ad26.cov2-s/tozinameranGuttate psoriasis: 2 case reports
Reactions Weekly, 2022, 1922 (1) : 25 - 25

← 1 2 3 4 5 →